COSMO Pharmaceuticals N.V.(CMOPF)
$67.00-4.59 (-6.41%)
CMOPF
COSMO Pharmaceuticals N.V. earnings date
$67.00
At close:-4.59 (-6.41%)
COSMO Pharmaceuticals N.V. (CMOPF) Q2 2018 Earnings Report
4 Followers
CMOPF Q2 2018 EPS Results
- Actual EPS
- -$0.75
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$1.58
CMOPF Q2 2018 Revenue Results
- Actual Revenue
- $52.99M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2018
- Date
- 07/26/2018
- Time
- Before Open
- Conference Call
- Thursday, July 26, 2018
CMOPF Upcoming Earnings
COSMO Pharmaceuticals N.V.'s next earnings date is estimated for March 24, 2027, based on past reporting schedules.
Q2 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
CMOPF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 24, 2027 | 2026 (Q4) | ―- | -0.12 | ― | ― |
| Jul 23, 2026 | 2026 (Q2) | 0.00-0.32 | -0.15 | -121.43% (-0.18) | |
| Mar 09, 2026 | 2025 (Q4) | 0.23-0.12 | 3.92 | -102.96% (-4.04) | |
| Jul 23, 2025 | 2025 (Q2) | ―-0.15 | 5.48 | -102.68% (-5.63) | |
| Mar 06, 2025 | 2024 (Q4) | 4.494.17 | -0.01 | 33840.00% (+4.18) | |
| Jul 24, 2024 | 2024 (Q2) | 0.675.48 | 0.11 | 5019.57% (+5.37) | |
| Mar 20, 2024 | 2023 (Q4) | 0.47-0.01 | 0.65 | -101.79% (-0.66) | |
| Jul 26, 2023 | 2023 (Q2) | ―0.11 | 0.55 | -80.67% (-0.45) | |
| Mar 23, 2023 | 2022 (Q4) | ―0.69 | 2.22 | -68.89% (-1.53) | |
| Jul 28, 2022 | 2022 (Q2) | ―0.55 | -0.46 | 219.30% (+1.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
